There are some new, unanswered questions about the busy intersection of COVID-19, the risks of diabetes, and the potential efficacy of medical marijuana in treatment.
A senior official at the DOJ’s antitrust division said that Barr inappropriately investigated cannabis company mergers and acquisitions because he “did not like the nature of their underlying business.”